Anti-HAT4/FLJ14154 antibody
Specifications
| Product Cat#: | AB-06-2096 |
| Product type: | Primary antibody |
| Antigen: | HAT4/FLJ14154 |
| Immunogen: | KLH conjugated synthetic peptide derived from human HAT4/FLJ14154 1-100/242 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:200-1:2000) |
| Reactivity: | Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | affinity purified by Protein A |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | FLJ11693 |
| FLJ14154 | |
| HAT4 | |
| Histone acetyltransferase type B protein 4 | |
| N acetyltransferase 15 (GCN5 related, putative) | |
| N alpha acetyltransferase 60 | |
| N(alpha) acetyltransferase 60, NatF catalytic subunit | |
| N-acetyltransferase 15 | |
| N-alpha-acetyltransferase 60 | |
| naa60 | |
| NAA60_HUMAN | |
| NAT15 |
Show More
Target information
N-alpha-acetyltransferase that specifically mediates the acetylation of N-terminal residues of the transmembrane proteins, with a strong preference for N-termini facing the cytosol (PubMed:25732826). Displays N-terminal acetyltransferase activity towards a range of N-terminal sequences including those starting with Met-Lys, Met-Val, Met-Ala and Met-Met (PubMed:21750686, PubMed:25732826, PubMed:27550639, PubMed:27320834). Required for normal chromosomal segregation during anaphase (PubMed:21750686). May also show histone acetyltransferase activity; such results are however unclear in vivo and would require additional experimental evidences (PubMed:21981917).
Provider
Erpantech Laboratory
